Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing propofol dosing for (preterm) newborn infants that need sedation for endotracheal intubation
2013-005572-17Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of propofol in None, sponsored by Erasmus MC. Primary endpoint: Optimal propofol dose for sedation. Started Mar 2014; status: active.
02
Drugs
propofol
Beyond the preview
Go deeper on 2013-005572-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005572-17.